JAKARTA, July 20, 2026 – Public health awareness across Indonesia has surged in recent years, with more people adopting active lifestyles through regular activities such as running, cycling, High-Intensity Interval Training (HIIT), and Hyrox. However, this enthusiasm is frequently sidelined by a common setback: muscle injuries and joint pain. When injuries occur, many individuals are forced to pause their fitness routines due to slow and painful recovery processes.

To address this growing issue, PYFAHEALTH has officially launched its latest innovation: X-Cool Pain Reliever Gel. Featuring premium European technology and quality standards, the product is engineered as a fast, effective solution for sports-related muscle recovery, helping active individuals get back on their feet without long-term disruptions.

Adi Prabowo, Associate Vice President of Marketing & Innovation at PYFA, explained that the launch of X-Cool reflects the company’s commitment to providing innovative, practical, and accessible healthcare solutions for fitness enthusiasts.

“Muscle injuries and joint pain are often the primary barriers preventing people from maintaining a consistent, active lifestyle,” said Prabowo. “With X-Cool Pain Reliever Gel, we are delivering a clinically tested, European-engineered solution that enables individuals to recover faster and return to their routines with confidence.”

Unlike traditional heat-inducing balms or creams, X-Cool utilizes Cold Therapy—a medically proven approach that is significantly more effective for treating acute injuries and early-stage muscle inflammation.

The gel’s premium formula bridges modern science and natural ingredients. It features MSM (0.75%) as a natural anti-inflammatory agent to relieve acute pain in inflamed muscle tissue, alongside Menthol (3.75%) to deliver an immediate cooling effect that soothes sensory nerve endings around the injured area. The formulation is further enhanced with peppermint and eucalyptus oils, providing a calming aromatherapeutic effect while aiding muscle relaxation.

The efficacy of cold gel formulations is supported by clinical research. According to an international study titled Efficacy of Cold Gel for Soft Tissue Injuries by Airaksinen O. et al., published in The American Journal of Sports Medicine (Vol. 31, No. 5), the use of cold gel significantly reduces pain intensity—measured on the Visual Analog Scale (VAS in mm)—starting as early as the first week compared to a placebo group.

In the study, both control and test groups recorded similar baseline pain scores. However, the cold gel group demonstrated a significantly sharper and more sustained drop in VAS scores throughout weeks 1, 2, and 4, showing statistically significant differences at every checkpoint. These findings indicate that the pain-relieving effects of cold gel formulas work rapidly during the acute phase while providing sustained support throughout the muscle and joint rehabilitation process.

For athletes and active individuals, X-Cool’s active formulation plays a crucial role in rapidly lowering pain intensity, improving clinical outcomes during muscle rehabilitation, and restoring optimal mobility to facilitate a faster return to physical training.

Designed for convenience, X-Cool can be applied directly to sore muscles or joints every 2 to 4 hours or as needed. Its fast-absorbing, non-sticky gel formulation ensures seamless application. Users are advised to avoid contact with eyes, open wounds, or irritated skin.

With the rollout of X-Cool, PYFAHEALTH reaffirms its commitment to supporting healthy, active lifestyles across Indonesia, ensuring muscle injuries no longer stand in the way of workout consistency.

X-Cool Pain Reliever Gel is now available through the official PYFAHEALTH store on major e-commerce platforms and in leading pharmacies nationwide.

About PYFA

PT Pyridam Farma Tbk, also known as PYFA, is a public pharmaceutical company listed on the Indonesia Stock Exchange (Ticker: PYFA). PYFA operates several business units producing prescription medicines in various forms, including tablets, capsules, creams, and injections. PYFA also has several well-known subsidiaries, including PT Holi Pharma, PT Ethica Industri Farmasi, and Probiotec Multipack.

Media Relations

Leilanie Nadia Kusuma
Head of Corporate Communications
Website : www.pyfa.co.id
Email : corcomm@pyfa.co.id